Dr. Mae C. Jemison
Mae C. Jemison blasted into orbit aboard the space shuttle Endeavour, September 12, 1992, the first woman of color to go into space. Now, founder and president of two technology companies, the space flight was just one of a series of accomplishments for this dynamic woman.
Born in Decatur, Ala. and raised in Chicago, she entered Stanford University as a scholarship student at age 16. After graduating with a B.S. in Chemical Engineering and fulfilling requirements for an A.B. in African and Afro-American studies, she earned her doctorate in medicine at Cornell University Medical College.
Prior to joining NASA in 1987, Dr. Jemison worked in both engineering and medicine. Following two and a half years as a Peace Corps medical officer for Sierra Leone and Liberia in West Africa, she worked as a general practitioner in Los Angeles.
As the science mission specialist on the STS-47 Spacelab J flight, a U.S./Japan joint mission, she conducted experiments in life sciences, material sciences, and co-investigated the Bone Cell Research experiment. After serving six years as a NASA astronaut, Dr. Jemison resigned from NASA in March 1993 to start The Jemison Group, Inc., to focus on the beneficial integration of science and technology into daily life.
In 1994, Dr. Jemison founded The Earth We Share, an annual international science camp where students, ages 12 to 16, work together to solve current global dilemmas.
As former professor of Environmental Studies at Dartmouth College, and director of the Jemison Institute for Advancing Technology in Developing Countries, Dr. Jemison is currently an A.D. White Professor-at-Large at Cornell University.
Her first book, "Find Where the Wind Goes: Moments from My Life," autobiographical anecdotes about growing up, was written for teenagers and was published in spring 2001 and released as a paperback in Jan. 2003.
Dr. Jemison's latest business venture, BioSentient Corporation, was created in July 1999 by The Jemison Group, Inc., which holds the exclusive license from NASA to commercialize exciting new technology. Originally designed to control motion sickness, BioSentient's technology presents significant opportunities across a wide spectrum of health and human performance areas.
Copyright 1995-2003, All rights reserved. Permission granted for non-commercial
National Organization for Women